Bladder Cancer Indication Withdrawn for Durvalumab ...Middle East

AstraZeneca is withdrawing durvalumab's indication for the treatment of metastatic bladder cancer after a phase 3 trial showed no survival benefit. Medscape Medical News

Hence then, the article about bladder cancer indication withdrawn for durvalumab was published today ( Tuesday 23/02/2021 - 06:00 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Bladder Cancer Indication Withdrawn for Durvalumab )

Also on site :

• Ukraine Spent Big to Shield Energy Industry From Drones. Is the Mideast Next?
• Tiger Woods’ Latest Move Has Golf World Buzzing About His Masters Plans
• Texas oil refinery in flames after explosion